News
The London-based owner of British Airways, Aer Lingus and Iberia revealed the group is currently paying less than 60% of the market rate for sustainable aviation fuel. This follows the firm's recent ...
The Prime Minister said he would invest in a military that is "more integrated, more ready, more lethal than ever". As part of the review, due to be published on Monday, the Government has pledged ...
(Alliance News) - A ban on disposable vapes goes into effect across the UK on Sunday in a bid to protect children's health and tackle a "throwaway" culture. "For too long, single-use vapes have ...
(Alliance News) - The UK government has sold its remaining shares in NatWest Group PLC and confirmed a GBP10.5 billion loss since the bank was rescued by UK taxpayers during the 2008 financial crisis.
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: ...
The FTSE 100 index closed up 55.93 points, 0.6%, at 8,772.38. The FTSE 250 ended up 30.43 points, 0.1%, at 21,028.01, and the AIM All-Share closed up 1.84 points, 0.3%, at 746.68.
The Saint Helier, Channel Islands-based firm makes vanadium batteries VS3 and Endurium, which are used to store renewable energy. Invinity posted annual revenue of GBP5 million, down 77% from GBP22 ...
NAV total return was minus 1.1% in the six months to March 31, beating its benchmark, the MSCI AC Asia excluding Japan, which had a return of minus 2.2%.
AJ Bell PLC - Manchester-based retail investment platform - Billy Mackay, managing director of Advised business, sells 39,922 shares at GBP5.01, worth GBP200,005, on Wednesday. Mackay now has 1.3 ...
Under the expiring programme that ran from May 2024 to May 2025, PetroTal was authorised to repurchase 14.6 million shares. As of May 20, it had bought back 5.4 million shares at an average price of ...
hVIVO has GBP47 million in revenue contracted for financial 2025, inclusive of cancellation and postponement fees, and anticipates further contract wins during the year. The company said it is in ...
Meanwhile, Merus, a Netherlands-based cancer cure developer, saw its shares jump after unveiling interim phase 2 data for its experimental antibody petosemtamab in combination with pembrolizumab for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results